Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale Chairman sold 25,000 shares at $35.50 ($887,500)
  4. 4 Grant or award Director acquired 8,259 shares (grant or award)
  5. 4 Grant or award Director acquired 8,259 shares (grant or award)
  6. 4 Grant or award Director acquired 8,259 shares (grant or award)
  7. 4 Grant or award Director acquired 8,259 shares (grant or award)
  8. 4 Grant or award Director acquired 8,259 shares (grant or award)
  9. 4 Grant or award Director acquired 8,259 shares (grant or award)
  10. 4 Grant or award Director acquired 8,259 shares (grant or award)
  11. 4 Open-market sale EVP, Biodefense Divison sold 11,419 shares at $28.62 ($326,808)
  12. 4 Gift EVP, Biodefense Divison gave 1,800 shares (gift)
  13. 4 Shares withheld for taxes EVP, Biodefense Divison gave up 2,700 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP, Corproate Services Div gave up 4,915 shares (to pay taxes)
  15. 4 Shares withheld for taxes President & CEO gave up 18,964 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chairman gave up 9,710 shares (to pay taxes)
  17. 4 Open-market sale Director sold 2,576 shares at $31.27 ($80,558)
  18. 4 Shares withheld for taxes EVP, Corproate Services Div gave up 1,799 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP, Biodefense Divison gave up 938 shares (to pay taxes)
  20. 4 Shares withheld for taxes President & CEO gave up 6,184 shares (to pay taxes)

Page 22 of 49 · 970 filings